Hank F Kung

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Journal of medicinal chemistry

Molecular pharmaceutics

European journal of nuclear medicine and molecular imaging

Journal of labelled compounds & radiopharmaceuticals

University of Pennsylvania (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Pennsylvania

United States

PHD :: Radiology

Publications

Linlin Li, Jiarou Wang, Guochang Wang, Rongxi Wang, Wenbin Jin, Jie Zang, Huimin Sui, Chenhao Jia, Yuanyuan Jiang, Haiyan Hong, Lin Zhu, David Alexoff, Karl Ploessl, Hank F Kung, Zhaohui Zhu
Comparison of novel PSMA-targeting [ 177 Lu]Lu-P17-087 with its albumin binding derivative [ 177 Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study. European journal of nuclear medicine and molecular imaging (2024)
Linlin Li, Jiarou Wang, Guochang Wang, Rongxi Wang, Wenbin Jin, Jie Zang, Huimin Sui, Chenhao Jia, Yuanyuan Jiang, Haiyan Hong, Lin Zhu, David Alexoff, Karl Ploessl, Hank F Kung, Zhaohui Zhu
Comparison of novel PSMA-targeting [ 177 Lu]Lu-P17-087 with its albumin binding derivative [ 177 Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Wenbin Jin, Ruiyue Zhao, Ran Wang, Seok Rye Choi, Karl Ploessl, David Alexoff, Zehui Wu, Lin Zhu, Hank F Kung
Theranostic Agent Targeting Bone Metastasis: A Novel [ 68 Ga]Ga/[ 177 Lu]Lu-DOTA-HBED-bisphosphonate. Journal of medicinal chemistry 67 (6) (2024)
Linlin Li, Jiarou Wang, Guochang Wang, Rongxi Wang, Wenbin Jin, Jie Zang, Huimin Sui, Chenhao Jia, Yuanyuan Jiang, Haiyan Hong, Lin Zhu, David Alexoff, Karl Ploessl, Hank F Kung, Zhaohui Zhu
Comparison of novel PSMA-targeting [ 177 Lu]Lu-P17-087 with its albumin binding derivative [ 177 Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Wenbin Jin, Ruiyue Zhao, Ran Wang, Seok Rye Choi, Karl Ploessl, David Alexoff, Zehui Wu, Lin Zhu, Hank F Kung
Theranostic Agent Targeting Bone Metastasis: A Novel [ 68 Ga]Ga/[ 177 Lu]Lu-DOTA-HBED-bisphosphonate. Journal of medicinal chemistry 67 (6) (2024)
Ran Wang, Wenbin Jin, Yang Luo, Haiyan Hong, Ruiyue Zhao, Linlin Li, Li Yan, Jinping Qiao, Karl Ploessl, Lin Zhu, Hank F Kung
Novel [ 68 Ga/ 177 Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy. Molecular pharmaceutics (2024)
Linlin Li, Jiarou Wang, Guochang Wang, Rongxi Wang, Wenbin Jin, Jie Zang, Huimin Sui, Chenhao Jia, Yuanyuan Jiang, Haiyan Hong, Lin Zhu, David Alexoff, Karl Ploessl, Hank F Kung, Zhaohui Zhu
Comparison of novel PSMA-targeting [ 177 Lu]Lu-P17-087 with its albumin binding derivative [ 177 Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Ran Wang, Wenbin Jin, Yang Luo, Haiyan Hong, Ruiyue Zhao, Linlin Li, Li Yan, Jinping Qiao, Karl Ploessl, Lin Zhu, Hank F Kung
Novel [ 68 Ga/ 177 Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy. Molecular pharmaceutics 21 (7) (2024)
Yang Luo, Wenbin Jin, Ran Wang, Ruiyue Zhao, Lin Zhu, Hank F Kung
68 Ga/ 177 Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer. Journal of medicinal chemistry (2024)
Yang Luo, Wenbin Jin, Ran Wang, Ruiyue Zhao, Lin Zhu, Hank F Kung
68 Ga/ 177 Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer. Journal of medicinal chemistry 67 (15) (2024)
Wenbin Jin, Ruiyue Zhao, Ran Wang, Seok Rye Choi, Karl Ploessl, David Alexoff, Zehui Wu, Lin Zhu, Hank F Kung
Theranostic Agent Targeting Bone Metastasis: A Novel [ 68 Ga]Ga/[ 177 Lu]Lu-DOTA-HBED-bisphosphonate. Journal of medicinal chemistry (2024)
Haiyan Hong, Zhihao Zha, Ruiyue Zhao, Yang Luo, Wenbin Jin, Linlin Li, Ran Wang, Li Yan, Hui Wang, Karl Ploessl, Jinping Qiao, Lin Zhu, Hank F Kung
[ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake. Molecular pharmaceutics (2023)
Zhihao Zha, Karl Ploessl, Seok Rye Choi, Ruiyue Zhao, Wenbin Jin, Ran Wang, David Alexoff, Lin Zhu, Hank F Kung
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy. Journal of medicinal chemistry (2023)
Zhihao Zha, Seok Rye Choi, Linlin Li, Ruiyue Zhao, Karl Ploessl, Xinyue Yao, David Alexoff, Lin Zhu, Hank F Kung
New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177). Journal of medicinal chemistry 65 (19) (2022)
Hao Xiao, Seok Rye Choi, Ruiyue Zhao, Karl Ploessl, David Alexoff, Lin Zhu, Zhihao Zha, Hank F Kung
A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain. ACS medicinal chemistry letters 12 (7) (2021)
Zhihao Zha, Seok Rye Choi, Karl Ploessl, David Alexoff, Ruiyue Zhao, Lin Zhu, Hank F Kung
Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [18F]AlF-P16-093. Bioconjugate chemistry 32 (5) (2021)
Zhihao Zha, Zehui Wu, Seok Rye Choi, Karl Ploessl, Megan Smith, David Alexoff, Lin Zhu, Hank F Kung
A New [68Ga]Ga-HBED-CC-Bisphosphonate as a Bone Imaging Agent. Molecular pharmaceutics 17 (5) (2020)
Lifang Zhang, Xinyue Yao, Jianhua Cao, Haiyan Hong, Aili Zhang, Ruiyue Zhao, Yan Zhang, Zhihao Zha, Yajing Liu, Jinping Qiao, Lin Zhu, Hank F Kung
In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia. Molecular pharmaceutics 16 (3) (2019)
Yan Zhang, Lifang Zhang, Jianhua Yang, Zehui Wu, Karl Ploessl, Zhihao Zha, Fei Liu, Xiaoxia Xu, Hua Zhu, Zhi Yang, Lin Zhu, Hank F Kung
Initial experience in synthesis of (2S,4R)-4-[18 F]fluoroglutamine for clinical application. Journal of labelled compounds & radiopharmaceuticals 62 (5) (2019)
Futao Liu, Lin Zhu, Seok Rye Choi, Karl Plössl, Zhihao Zha, Hank F Kung
Deuterium-substituted 2-(2'-((dimethylamino)methyl)-4'-[18 F](fluoropropoxy)phenylthio)benzenamine as a serotonin transporter imaging agent. Journal of labelled compounds & radiopharmaceuticals 61 (8) (2018)

Hank F Kung.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hank F Kung